Pizotifen (Hydrogen Maleate)
Overview
Stavudine is an antiviral agent. Stavudine is a nucleoside reverse transcriptase inhibitor. Stavudine is used in patients with AIDS for whom ZIDOVUDINE is inappropriate. Stavudine is either used alone or in combination with other antiretroviral agents in the treatment of HIV infection.
Categories
- 7 Antimigraine preparations
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Pizotifen (Hydrogen Maleate)'s dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
0.5 mg | 0.5 (0.5) | 8 hourly | PO | Maintenance dose, |
0.5 mg | 0.5 (0.5) | As recommended. | PO | Initial dose |
Paedriatic Dosage (20kg)
|
0.02 mg/kg | 0.02 (0.02) | 8 hourly | Oral | Dose for Children of 5-12 Yrs |
Neonatal Dosage (3kg)
|
No data regarding the neonatal dosage details of Pizotifen (Hydrogen Maleate) is available. |
High Risk Groups
Drug should not be given to Pregnant Mothers, and patients suffering from Kidney dysfunction.
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Pizotifen (Hydrogen Maleate)
Back to top
Manufacturers of
Pizotifen (Hydrogen Maleate)
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic